MSLAB promotes Dermatonics products in French-speaking Africa

24-12-2022

Renowned for their effectiveness, Dermatonics products complete the MSLAB range and strengthen its support in the treatment of various forms of diabetes and its consequences, which affects more than 25 million Africans and is progressing rapidly. Africa is the continent with the highest number of people who do not know their diabetes status. It is estimated that 70% of people with diabetes do not know that they are affected by this disease. Detection and treatment of the consequences of diabetes are essential factors of health in Africa. About Dermatonics Dermatonics was established in 2008 in the UK. Dermatonics manufactures innovative topical and dermatological products that have greater efficacy and demonstrable benefits compared to other products currently available. And always using natural ingredients whenever possible. More information at dermatonics.co.uk